Glycot Therapeutics, LLC SBIR Phase I Award, August 2019
A SBIR Phase I contract was awarded to GlycoT Therapeutics in August, 2019 for $150,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Name
# Contributions
Last Contribution
Find more entities like Glycot Therapeutics, LLC SBIR Phase I Award, August 2019
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.